CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 87 filers reported holding CABALETTA BIO INC in Q2 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $111,000 | – | 13,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,082,973 | $35,535,519 | 9.15% |
| STEMPOINT CAPITAL LP | 1,003,916 | $17,126,807 | 4.53% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 290,797 | $4,960,997 | 3.28% |
| Bain Capital Life Sciences Investors, LLC | 1,617,364 | $27,592,230 | 2.22% |
| Ghost Tree Capital, LLC | 375,000 | $6,397,500 | 1.77% |
| VR Adviser, LLC | 1,563,952 | $26,681,021 | 1.27% |
| COMMODORE CAPITAL LP | 1,100,000 | $18,766,000 | 1.26% |
| Saturn V Capital Management LP | 173,173 | $2,954,331 | 1.18% |
| Cutter Capital Management, LP | 315,928 | $5,389,732 | 1.04% |
| Cormorant Asset Management, LP | 1,100,000 | $18,766,000 | 0.82% |